SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Reddy's gets DCGI’s nod for single-shot Sputnik Light vaccine

07 Feb 2022 Evaluate

Dr. Reddy's Laboratories has received the Drugs Controller General of India (DCGI) approval for the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.

Sputnik Light is a one-dose vaccine and the same as the first component-recombinant human adenovirus serotype number 26 (rAd26)-of the two-dose Sputnik V vaccine. Following its Phase III clinical trial of the single-shot Sputnik Light vaccine in India, Dr. Reddy’s had submitted its application for approval to the DCGI in December 2021, in addition to data from clinical trial in Russia.

The standalone Sputnik Light vaccine is the latest vaccine to be approved by the DCGI as part of India’s national inoculation effort against COVID-19. Sputnik Light is the second COVID-19 vaccine to be made available in India by Dr. Reddy’s, reaffirming the company’s commitment to explore every avenue in the fight against the pandemic.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1320.00 49.05 (3.86%)
06-May-2026 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1853.20
Dr. Reddys Lab 1320.00
Cipla 1368.45
Zydus Lifesciences 938.80
Lupin 2444.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×